SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.01.12 | Novartis halten | Independent Research GmbH | |
| 25.01.12 | Novartis buy | Sarasin Research | |
| 25.01.12 | Lonza neutral | Sarasin Research | |
| 24.01.12 | Novartis buy | Sarasin Research | |
| 24.01.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 23.01.12 | Novartis buy | Nomura | |
| 20.01.12 | Novartis buy | Nomura | |
| 20.01.12 | Novartis overweight | J.P. Morgan Cazenove | |
| 18.01.12 | Novartis halten | Independent Research GmbH | |
| 18.01.12 | Tecan (N) hold | Vontobel Research | |
| 18.01.12 | Novartis hold | Vontobel Research | |
| 17.01.12 | Novartis buy | Nomura | |
| 17.01.12 | COLTENE hold | Vontobel Research | |
| 16.01.12 | Novartis buy | WestLB AG | |
| 13.01.12 | Novartis buy | Sarasin Research | |
| 13.01.12 | Novartis hold | Vontobel Research | |
| 12.01.12 | Novartis buy | Nomura | |
| 09.01.12 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 09.01.12 | Novartis hold | Vontobel Research | |
| 09.01.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 05.01.12 | Novartis overweight | J.P. Morgan Cazenove | |
| 05.01.12 | Basilea Pharmaceutica buy | Sarasin Research | |
| 05.01.12 | Newron PharmaceuticalsAz. hold | Vontobel Research | |
| 05.01.12 | Basilea Pharmaceutica hold | Vontobel Research | |
| 04.01.12 | Novartis buy | Deutsche Bank AG | |
| 27.12.11 | Novartis kaufen | Raiffeisen Centrobank AG | |
| 23.12.11 | Novartis neutral | Goldman Sachs Group Inc. | |
| 21.12.11 | Novartis overweight | J.P. Morgan Cazenove | |
| 21.12.11 | Novartis hold | Vontobel Research | |
| 16.12.11 | Novartis outperform | Credit Suisse Group | |
| 15.12.11 | Novartis hold | Vontobel Research | |
| 14.12.11 | Novartis overweight | J.P. Morgan Cazenove | |
| 13.12.11 | Novartis buy | WestLB AG | |
| 13.12.11 | Novartis hold | Vontobel Research | |
| 13.12.11 | Novartis outperform | Credit Suisse Group | |
| 08.12.11 | Novartis hold | Vontobel Research | |
| 06.12.11 | Novartis hold | Vontobel Research | |
| 05.12.11 | Straumann hold | Vontobel Research | |
| 02.12.11 | Tecan (N) hold | Vontobel Research | |
| 01.12.11 | Novartis neutral | Citigroup Corp. |